{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:20:11Z","timestamp":1789471211157,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["61589331"],"award-info":[{"award-number":["61589331"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022752","name":"MSD Sharp & Dohme GmbH","doi-asserted-by":"publisher","award":["60314 IIS"],"award-info":[{"award-number":["60314 IIS"]}],"id":[{"id":"10.13039\/100022752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.vaccine.2025.126848","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T03:37:58Z","timestamp":1738899478000},"page":"126848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Impact of the 10-valent pneumococcal conjugate vaccine (PCV10) on pneumococcal carriage in healthy children and children with acute otitis media and pneumonia: emergence of serotypes 3, 6C and 19A in Croatia"],"prefix":"10.1016","volume":"50","author":[{"given":"Nina","family":"Krajcar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Trkulja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Buti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Te\u0161ovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126848_bb0005","series-title":"Pneumococcal conjugate vaccines in infants and children under 5 years of age","author":"WHO position paper","year":"2019"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126848_bb0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126848_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126848_bb0020","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"Dagan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126848_bb0025","author":"VIEW-hub Report"},{"key":"10.1016\/j.vaccine.2025.126848_bb0030","series-title":"Evidence to recommendation framework Question: Is the impact or effectiveness of PCV10 and PCV13 (using either WHO recommended dosing schedules) different?","author":"SAGE","year":"2019"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126848_bb0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/INF.0b013e3181f87802","article-title":"Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential","volume":"30","author":"Greenberg","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126848_bb0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/INF.0b013e318280ab45","article-title":"Evaluation of concordance between the microorganisms detected in the nasopharynx and middle ear of children with otitis media","volume":"32","author":"Van Dongen","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126848_bb0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/cid\/ciz277","article-title":"Serotypes of streptococcus pneumoniae in children aged <5 years hospitalized with or without pneumonia in developing and emerging countries: a descriptive, multicenter study","volume":"70","author":"Dananch\u00e9","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126848_bb0050","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1186\/s12879-014-0640-y","article-title":"Correlation of nasopharyngeal cultures prior to and at onset of acute otitis media with middle ear fluid cultures","volume":"14","author":"Kaur","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126848_bb0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3325\/cmj.2022.63.156","article-title":"Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates among Croatian adults during a fifteen-year period (2005-2019)","volume":"63","author":"Buti\u0107","year":"2022","journal-title":"Croat Med J"},{"key":"10.1016\/j.vaccine.2025.126848_bb0060","series-title":"Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Croatia [dissertation]","author":"Buti\u0107","year":"2022"},{"key":"10.1016\/j.vaccine.2025.126848_bb0065","first-page":"1480348","article-title":"Invasive pneumococcal disease in adults after the introduction of pneumococcal vaccination: a retrospective study in the metropolitan area of Zagreb, Croatia (2010\u22122022). Front","volume":"12","author":"\u010civljak","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.vaccine.2025.126848_bb0070","article-title":"The epidemiology of invasive Streptococcus pneumoniae disease in Croatian children","volume":"14(12):PH59-64","author":"Gu\u017evinec","year":"2008","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.vaccine.2025.126848_bb0075","author":"World Health Organization Pneumonia Vaccine Trial Investigators'\u2019 Group"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126848_bb0080","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1542\/peds.2012-3488","article-title":"The diagnosis and Management of Acute Otitis Media","volume":"131","author":"Lieberthal","year":"2013","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126848_bb0085","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1198-743X.2004.00926.x","article-title":"A cross-sectional survey of the prevalence of Streptococcus pneumoniae nasopharyngeal carriage in Belgian infants attending day care centres","volume":"10","author":"Malfroot","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126848_bb0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.22.3.269","article-title":"The action of ethylhydrocuprein (optochin) on type strains of pneumococci in vitro and in vivo, and on some other microorganisms in vitro","volume":"22","author":"Moore","year":"1915","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2025.126848_bb0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0732-8893(03)00160-3","article-title":"Manual of clinical microbiology 8th edition","volume":"47","author":"Balows","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126848_bb0100","author":"The European Committee on Antimicrobial Susceptibility Testing"},{"key":"10.1016\/j.vaccine.2025.126848_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/pan\/mpr025","article-title":"Entropy balancing for causal effects: a multivariate reweighting method to produce balanced samples in observational studies","volume":"20","author":"Hainmueller","year":"2012","journal-title":"Polit Anal"},{"key":"10.1016\/j.vaccine.2025.126848_bb0110","first-page":"1","article-title":"Optimal full matching and related designs via network flows","volume":"15","author":"Hansen","year":"2006","journal-title":"J Computational Global Stat"},{"key":"10.1016\/j.vaccine.2025.126848_bb0115","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/pan.2019.11","article-title":"Why propensity scores should not be used for matching","volume":"27","author":"King","year":"2019","journal-title":"Polit Anal"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126848_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIT: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2025.126848_bb0125","author":"WeightIt"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126848_bb0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"},{"issue":"39","key":"10.1016\/j.vaccine.2025.126848_bb0135","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1016\/j.vaccine.2017.08.020","article-title":"Pneumococcal vaccination: direct and herd effect on carriage of vaccine types and antibiotic resistance in Icelandic children","volume":"35","author":"Sigurdsson","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126848_bb0140","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/vaccines10050791","article-title":"Impact of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae and microbiota profiles in preschool children in south East Poland","volume":"10","author":"Kielbik","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.126848_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2021.11.021","article-title":"Pneumococcal carriage among children in low and lower-middle-income countries: a systematic review","volume":"115","author":"Tvedskov","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126848_bb0150","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jiac376","article-title":"Nasopharyngeal carriage of pneumococcus in children in England up to 10 years after 13-valent pneumococcal conjugate vaccine introduction: persistence of serotypes 3 and 19A and emergence of 7C","volume":"227","author":"Tiley","year":"2023","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126848_bb0155","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s40121-021-00544-1","article-title":"Clinical and economic burden of pneumococcal disease due to serotypes contained in current and investigational pneumococcal conjugate vaccines in children under five years of age","volume":"10","author":"Wasserman","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126848_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194823","article-title":"Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in the Netherlands","volume":"13","author":"Vissers","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126848_bb0165","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/14760584.2019.1627207","article-title":"Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation","volume":"18","author":"Dagan","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126848_bb0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jpids\/piw010","article-title":"Effectiveness of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-a double-blind randomized clinical trial in Finland","volume":"5","author":"Vesikari","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126848_bb0175","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/S2214-109X(14)70224-4","article-title":"Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies","volume":"2","author":"Hammitt","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126848_bb0180","doi-asserted-by":"crossref","first-page":"e1375","DOI":"10.1016\/S2214-109X(18)30383-8","article-title":"Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys","volume":"6","author":"Dunne","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"15","key":"10.1016\/j.vaccine.2025.126848_bb0185","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.vaccine.2018.03.001","article-title":"Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland","volume":"36","author":"Rinta-Kokko","year":"2018","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2025.126848_bb0190","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.vaccine.2018.04.010","article-title":"Distribution of invasive Streptococcus pneumoniae serotypes before and 5\u00a0years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil","volume":"36","author":"Brandileone","year":"2018","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126848_bb0195","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/cid\/cix685","article-title":"Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations","volume":"65","author":"Naucler","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126848_bb0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1473-3099(20)30173-0","article-title":"Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study","volume":"21","author":"Desmet","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126848_bb0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/jpids\/piac117","article-title":"Serotype 19A and 6C account for one-third of pneumococcal carriage among Belgian day-care children four years after a shift to a lower-valent PCV","volume":"12","author":"Ekinci","year":"2023","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"46","key":"10.1016\/j.vaccine.2025.126848_bb0210","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1016\/j.vaccine.2016.09.027","article-title":"Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in S\u00e3o Paulo, Brazil","volume":"34","author":"de Cunto Brandileone","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126848_bb0215","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","volume":"2","author":"Domingues","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"36","key":"10.1016\/j.vaccine.2025.126848_bb0220","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.vaccine.2019.07.043","article-title":"Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil","volume":"37","author":"de Cunto Brandileone","year":"2019","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126848_bb0225","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/14760584.2017.1362339","article-title":"Streptococcus pneumoniae serotype 19A: worldwide epidemiology","volume":"16","author":"Isturiz","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126848_bb0230","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/j.vaccine.2024.03.065","article-title":"Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance","volume":"42","author":"Grant","year":"2024","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2025.126848_bb0235","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2017.04.019","article-title":"Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: the emergence of multidrug resistant serotype 6C","volume":"35","author":"Neves","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126848_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.613287","article-title":"Sugar-coated killer: serotype 3 pneumococcal disease","volume":"10","author":"Luck","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"29","key":"10.1016\/j.vaccine.2025.126848_bb0245","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.vaccine.2022.05.011","article-title":"Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study","volume":"40","author":"Savulescu","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126848_bb0250","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40121-021-00406-w","article-title":"Pneumococcal conjugate vaccine impact on serotype 3: a review of surveillance data","volume":"10","author":"Sings","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126848_bb0255","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/cid\/ciy920","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: a systematic review and Meta-analysis of observational studies","volume":"68","author":"Sings","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2025.126848_bb0260","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1016\/j.vaccine.2024.04.061","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: an indirect cohort study","volume":"42","author":"Andrejko","year":"2024","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126848_bb0265","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jiac376","article-title":"Nasopharyngeal carriage of pneumococcus in children in England up to 10 years after 13-valent pneumococcal conjugate vaccine introduction: persistence of serotypes 3 and 19A and emergence of 7C","volume":"227","author":"Tiley","year":"2023","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126848_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007438","article-title":"Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci","volume":"14","author":"Azarian","year":"2018","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126848_bb0275","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.18959","article-title":"Association of Nonpharmaceutical Interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral infections among children in France","volume":"5","author":"Rybak","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126848_bb0280","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1093\/cid\/ciab1014","article-title":"Decline in pneumococcal disease in young children during the coronavirus disease 2019 (COVID-19) pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: a prospective cohort study","volume":"75","author":"Danino","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126848_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.825427","article-title":"Infant pneumococcal carriage in Belgium not affected by COVID-19 containment measures","volume":"11","author":"Willen","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126848_bb0290","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:30:03Z","timestamp":1741793403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25001458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":58,"alternative-id":["S0264410X25001458"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126848","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the 10-valent pneumococcal conjugate vaccine (PCV10) on pneumococcal carriage in healthy children and children with acute otitis media and pneumonia: emergence of serotypes 3, 6C and 19A in Croatia","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126848"}}